-+ 0.00%
-+ 0.00%
-+ 0.00%

Studsvik (OM:SVIK) Stock Q3 Earnings Struggle To Support Rich Valuation

Simply Wall St·10/25/2026 01:35:30
语音播报

Studsvik entered Q3 2026 earnings with a hot reputation and a cooling share chart, after the stock declined about 11% over the past month and 7% over the past week to close at SEK200.5 on 23 October. The company just reported Q3 revenue of SEK227.4m and net income of SEK0.7m, which translates to basic earnings per share of SEK0.09. That is a thin profit line for a stock trading on a P/E of 62.4x. The one-day price move now has to be weighed against a quarter that puts the valuation premium under sharper scrutiny.

Like the nuclear story at Studsvik but uneasy about paying 62.4x earnings for a razor thin SEK0.09 EPS quarter? Scan a wider field of quality nuclear and infrastructure plays in our 16 nuclear energy infrastructure stocks

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): SEK227.4m vs. SEK205.8m (up 10.5%).
  • Net Income (Q3 2026 vs. Q3 2025): SEK0.7m vs. SEK3.6m (down 80.6%).
  • Basic EPS (Q3 2026 vs. Q3 2025): SEK0.09 vs. SEK0.43803 (down 79.5%).
  • Operating Margin (Q3 2026): 3.2% operating margin on SEK227.4m revenue, based on SEK7.2m operating profit.

Prefer clean charts to long earnings tables and dense commentary? View Studsvik's full financial picture, including a visual look at its valuation, analyst context and recent share price action, in the company report for Studsvik.

OM:SVIK Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
OM:SVIK Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Studsvik bullish story leans on revenue and backlog

Studsvik gives bulls some real fuel. Group sales rose 10.7% in local currency, ahead of the 6% growth ambition, with Scandpower up 42.3% and DRPS improving both revenue and profitability. The NND frame agreement of SEK3–4b plus the Fukushima inDRUM licensing deal add long dated visibility that fits the nuclear lifecycle partner story. Free cash flow was weak in Q3, yet operating cash flow before working capital was positive, which supports management’s description of a cash generating core business funding future opportunities.

Profitability squeeze and cash drag temper enthusiasm

The flip side is earnings quality. Net income fell sharply year on year to SEK0.7m and group margin sat at 3.2%, even as DRPS margins improved. Investments in BlackStarTech, SMR/AMR products and inDRUM, together with working capital outflows, left free cash flow down SEK35.3m in the quarter and SEK107.3m year to date. Studsvik’s growth initiatives and multi decade contracts are attractive on paper, yet the immediate picture still shows thin profitability and lumpy cash conversion that cautious investors will focus on.

After earnings this thin and cash conversion this lumpy, the real question is whether Studsvik has deeper structural issues that the headline numbers mask. Review our independent risk analysis for Studsvik which shows 2 important warning signs

Hunt For Quiet Mispricings

Studsvik just showed how a busy quarter on paper can still leave investors debating the price they are paying. The real opportunity is finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 35% below our estimate - runs complex manufacturing programs in regulated sectors as a record opportunity funnel converts into production work.
  • Company 2 - 42% below our estimate - builds an integrated complex care network as new facilities and higher-acuity services increase patient volumes and operating leverage.
  • Company 3 - 30% below our estimate - supplies photonic systems into semiconductor and biophotonics projects as customers prepare fresh capacity ramps and higher-value product orders.

Three companies from the same screener. Open all 195 potentially undervalued companies →